Shelter Pharma Ltd
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Animal and Poultry Healthcare Distributors Number ・Standalone data |
|
||
| Human Healthcare Distributors Number ・Standalone data |
|||
| Human Resource Strength (Employees) Number ・Standalone data |
|||
| Number of Export Countries Number ・Standalone data |
|||
| Number of Formulations Number ・Standalone data |
|||
| Trade Receivable Turnover Ratio Ratio ・Standalone data |
|||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Investor Presentation
2d - Submission of Investor Presentation for H2 & FY2026- Investor Conference Call.
-
Corrigendum To Intimation Of H2 FY2026 Investor Conference Call
16 Jun - Corrected investor conference call day to Friday, 19 June 2026 at 4:00 PM IST.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Jun - Intimation of shelter pharma limited- Company H2 FY2026 Investor Call.
-
Corrigendum To Intimation Of H2 FY2026 Investor Conference Call Withdrawal Of Scheduled Meeting
8 Jun - H2 FY2026 investor conference call scheduled for 10 June 2026 has been cancelled; revised date will follow.
-
Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Completion And Commencement Of Dispatch Of Export Order
8 Jun - Completed and began dispatch of USD 141,600 Joemega Capsules export order; USD 118,634 dispatched so far.
Annual reports
Concalls
-
Jun 2026TranscriptAI SummaryPPT
Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals